ArticleNeurochemical research2025
Glioprotective Effects of Ilex paraguariensis Standardized Extract Through Nrf2 Activation and NF-κB Suppression in lipopolysaccharide-treated Astrocytes.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ilex paraguariensis (IP) is a plant native to South America, traditionally consumed as a beverage and holding significant economic and social value. This plant has been associated with a range of pharmacological activities, including anti-inflammatory and antioxidant effects. Although some studies have suggested its neuroprotective properties, the effects of IP on glial cells, particularly astrocytes, remain poorly understood. Astrocytes play a crucial role in the neuroinflammatory response, and dysfunction in these cells can contribute to the development of neurodegenerative diseases. This study aimed to investigate the glioprotective mechanisms of a standardized IP extract against inflammatory and oxidative damage induced by lipopolysaccharide (LPS) in primary astrocyte cultures. Astrocytes were treated with IP extract (10, 30, 100, and 300 µg/mL) for 24 h, followed by a 3-hour exposure to LPS (1 µg/mL). LPS exposure resulted in the up-regulation of mRNA expression of interleukin-1β and nuclear factor-kappa B genes, increased cell proliferation, and acetylcholinesterase activity, elevated levels of reactive oxygen and nitrogen species, and reduced astrocytic viability, Na
Indexed as
Identifiers
41051699What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.